MicroRNA-150 Suppression of Angiopoetin-2 Generation and Signaling Is Crucial for Resolving Vascular Injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 2, 2016, Pages 380-388

  Rajput, Charu ^a   Tauseef, Mohammad ^a   Farazuddin, Mohammad ^a   Yazbeck, Pascal ^a   Amin, Md Ruhul ^a   Avin Br, Vijay ^a   Sharma, Tiffany ^a   Mehta, Dolly ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

adherens junctions; angiopoietin 2; endothelial growth response 2; endothelium; lung injury; miR 150; sepsis

Indexed keywords

ANGIOPOIETIN 2; BETA CATENIN; EARLY GROWTH RESPONSE FACTOR 2; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 150; MYOSIN LIGHT CHAIN KINASE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; ANGPT2 PROTEIN, HUMAN; EGR2 PROTEIN, HUMAN; MIRN150 MICRORNA, HUMAN; MIRN150 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SEPSIS; SIGNAL TRANSDUCTION; ADHERENS JUNCTION; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL CULTURE; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GENOTYPE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHENOTYPE; PULMONARY ARTERY; TIME FACTOR; VASCULAR DISEASES; VASCULAR REMODELING;

ADHERENS JUNCTIONS; ANGIOPOIETIN-2; ANIMALS; CAPILLARY PERMEABILITY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 2; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENOTYPE; LIPOPOLYSACCHARIDES; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PHENOTYPE; PULMONARY ARTERY; SEPSIS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VASCULAR DISEASES; VASCULAR REMODELING;

EID: 84955708236     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306997     Document Type: Article

References (52)

1. Mehta D, Malik AB, Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006 86 279 367. doi: 10.1152/physrev.00012.2005.
2. Komarova YA, Mehta D, Malik AB, Dual regulation of endothelial junctional permeability. Sci STKE 2007 2007 re8. doi: 10.1126/stke.4122007re8.
3. Tauseef M, Knezevic N, Chava KR, Smith M, Sukriti S, Gianaris N, Obukhov AG, Vogel SM, Schraufnagel DE, Dietrich A, Birnbaumer L, Malik AB, Mehta D, TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. J Exp Med 2012 209 1953 1968. doi: 10.1084/jem.20111355.
4. Vandenbroucke E, Mehta D, Minshall R, Malik AB, Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008 1123 134 145. doi: 10.1196/annals.1420.016.
5. Gonzales JN, Gorshkov B, Varn MN, Zemskova MA, Zemskov EA, Sridhar S, Lucas R, Verin AD, Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2014 306 L497 L507. doi: 10.1152/ajplung.00086.2013.
6. Fu P, Usatyuk PV, Lele A, Harijith A, Gregorio CC, Garcia JG, Salgia R, Natarajan V, c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury. Am J Physiol Lung Cell Mol Physiol 2015 308 L1025 L1038. doi: 10.1152/ajplung.00306.2014.
7. Knezevic N, Tauseef M, Thennes T, Mehta D, The G protein betagamma subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin. J Exp Med 2009 206 2761 2777. doi: 10.1084/jem.20090652.
8. Matthay MA, Zemans RL, The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011 6 147 163. doi: 10.1146/annurev-pathol-011110-130158.
9. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP, Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006 3 e46. doi: 10.1371/journal.pmed.0030046.
10. Thurston G, Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 2003 314 61 68. doi: 10.1007/s00441-003-0749-6.
11. Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD, Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation. Cold Spring Harb Symp Quant Biol 2002 67 267 273
12. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, Lee PJ, Geick A, de Fougerolles AR, Elias JA, Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006 12 1286 1293. doi: 10.1038/nm1494.
13. Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, Papapetropoulos A, Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005 314 738 744. doi: 10.1124/jpet.105.086553.
14. Mammoto T, Jiang E, Jiang A, Lu Y, Juan AM, Chen J, Mammoto A, Twist1 controls lung vascular permeability and endotoxin-induced pulmonary edema by altering Tie2 expression. PLoS One 2013 8 e73407. doi: 10.1371/journal.pone.0073407.
15. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C, Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007 35 199 206. doi: 10.1097/01.CCM.0000251640.77679.D7.
16. Wada T, Jesmin S, Gando S, Yanagida Y, Mizugaki A, Sultana SN, Zaedi S, Yokota H, The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) associated with critical illness. J Inflamm (Lond) 2013 10 6. doi: 10.1186/1476-9255-10-6.
17. Diamond JM, Porteous MK, Cantu E, Lung Transplant Outcomes Group Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One 2012 7 e51932. doi: 10.1371/journal.pone.0051932.
18. Meyer NJ, Li M, Feng R, ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011 183 1344 1353. doi: 10.1164/rccm.201005-0701OC.
19. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD, Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000 6 460 463. doi: 10.1038/74725.
20. Chu D, Sullivan CC, Du L, Cho AJ, Kido M, Wolf PL, Weitzman MD, Jamieson SW, Thistlethwaite PA, A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1. Ann Thorac Surg 2004 77 449 456; discussion 456. doi: 10.1016/S0003-4975(03)01350-X.
21. Sullivan CC, Du L, Chu D, Cho AJ, Kido M, Wolf PL, Jamieson SW, Thistlethwaite PA, Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci USA 2003 100 12331 12336. doi: 10.1073/pnas.1933740100.
22. Thistlethwaite PA, Lee SH, Du LL, Wolf PL, Sullivan C, Pradhan S, Deutsch R, Jamieson SW, Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg 2001 122 65 73. doi: 10.1067/mtc.2001.113753.
23. Bartel DP, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 281 297
24. Ichimura A, Ruike Y, Terasawa K, Tsujimoto G, miRNAs and regulation of cell signaling. FEBS J 2011 278 1610 1618. doi: 10.1111/j.1742-4658.2011.08087.x.
25. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA, MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009 4 e7405. doi: 10.1371/journal.pone.0007405.
26. Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F, Luedde T, Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 2013 8 e54612. doi: 10.1371/journal.pone.0054612.
27. Luo Z, Wen G, Wang G, Pu X, Ye S, Xu Q, Wang W, Xiao Q, MicroRNA-200C and-150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1. Stem Cells 2013 31 1749 1762. doi: 10.1002/stem.1448.
28. Tauseef M, Kini V, Knezevic N, Brannan M, Ramchandaran R, Fyrst H, Saba J, Vogel SM, Malik AB, Mehta D, Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res 2008 103 1164 1172. doi: 10.1161/01.RES.0000338501.84810.51.
29. Zhao YY, Gao XP, Zhao YD, Mirza MK, Frey RS, Kalinichenko VV, Wang IC, Costa RH, Malik AB, Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. J Clin Invest 2006 116 2333 2343. doi: 10.1172/JCI27154.
30. Gallagher DC, Parikh SM, Balonov K, Miller A, Gautam S, Talmor D, Sukhatme VP, Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2008 29 656 661. doi: 10.1097/shk.0b013e31815dd92f.
31. Chava KR, Karpurapu M, Wang D, Bhanoori M, Kundumani-Sridharan V, Zhang Q, Ichiki T, Glasgow WC, Rao GN, CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2009 29 809 815. doi: 10.1161/ATVBAHA.109.185777.
32. Minami T, Jiang S, Schadler K, Suehiro J, Osawa T, Oike Y, Miura M, Naito M, Kodama T, Ryeom S, The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases. Cell Rep 2013 4 709 723. doi: 10.1016/j.celrep.2013.07.021.
33. Deleuze V, El-Hajj R, Chalhoub E, Dohet C, Pinet V, Couttet P, Mathieu D, Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells. PLoS One 2012 7 e40484. doi: 10.1371/journal.pone.0040484.
34. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S, Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 2005 115 2382 2392. doi: 10.1172/JCI23126.
35. Dweep H, Sticht C, Pandey P, Gretz N, miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011 44 839 847. doi: 10.1016/j.jbi.2011.05.002.
36. Taylor MA, Schiemann WP, Therapeutic opportunities for targeting microRNAs in cancer. Mol Cell Ther 2014 2 1 13. doi: 10.1186/2052-8426-2-30.
37. Holinstat M, Knezevic N, Broman M, Samarel AM, Malik AB, Mehta D, Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability. J Biol Chem 2006 281 2296 2305. doi: 10.1074/jbc.M511248200.
38. Young JA, Ting KK, Li J, Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood 2013 122 2911 2919. doi: 10.1182/blood-2012-12-473017.
39. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M, In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun 2009 380 437 441. doi: 10.1016/j.bbrc.2008.12.190.
40. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997 277 55 60
41. Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J, Ioffe E, Daly TJ, Fandl JP, Papadopoulos N, McDonald DM, Thurston G, Yancopoulos GD, Rudge JS, Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 2006 103 15491 15496. doi: 10.1073/pnas.0607538103.
42. Tasaka S, Koh H, Yamada W, Shimizu M, Ogawa Y, Hasegawa N, Yamaguchi K, Ishii Y, Richer SE, Doerschuk CM, Ishizaka A, Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632. Am J Respir Cell Mol Biol 2005 32 504 510. doi: 10.1165/rcmb.2004-0009OC.
43. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007 9 654 659. doi: 10.1038/ncb1596.
44. Deng L, Blanco FJ, Stevens H, MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circ Res 2015 117 870 883. doi: 10.1161/CIRCRESAHA.115.306806.
45. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K, MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007 131 146 159. doi: 10.1016/j.cell.2007.07.021.
46. Menden H, Welak S, Cossette S, Ramchandran R, Sampath V, Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells. J Biol Chem 2015 290 5449 5461. doi: 10.1074/jbc.M114.600692.
47. Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM, Martijn C, Rondahl L, Krauli P, Walum E, Enerbäck S, Cao Y, FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc Natl Acad Sci USA 2008 105 10167 10172. doi: 10.1073/pnas.0802486105.
48. Fang F, Ooka K, Bhattacharyya S, Bhattachyya S, Wei J, Wu M, Du P, Lin S, Del Galdo F, Feghali-Bostwick CA, Varga J, The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am J Pathol 2011 178 2077 2090. doi: 10.1016/j.ajpath.2011.01.035.
49. Chandra A, Lan S, Zhu J, Siclari VA, Qin L, Epidermal growth factor receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing early growth response 2 (EGR2) expression. J Biol Chem 2013 288 20488 20498. doi: 10.1074/jbc.M112.447250.
50. Poirier R, Cheval H, Mailhes C, Garel S, Charnay P, Davis S, Laroche S, Distinct functions of egr gene family members in cognitive processes. Front Neurosci 2008 2 47 55. doi: 10.3389/neuro.01.002.2008.
51. Dillon RL, Brown ST, Ling C, Shioda T, Muller WJ, An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer. Mol Cell Biol 2007 27 8648 8657. doi: 10.1128/MCB.00866-07.
52. McCarter SD, Mei SH, Lai PF, Zhang QW, Parker CH, Suen RS, Hood RD, Zhao YD, Deng Y, Han RN, Dumont DJ, Stewart DJ, Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007 175 1014 1026. doi: 10.1164/rccm.200609-1370OC.